Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NuCana PLC NCNA

NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-3373, and NUC-7738. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). 5-FU is a prescribed anti-cancer agent. NUC... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:NCNA)

No current opinion is available.

Bullboard Posts (NDAQ:NCNA)

US Companies Moving the Markets, Morning edition <br>Tue, Ap

Just In: $NCNA US Companies Moving the Markets, Morning edition Tue, Apr 16, 2024 as of 10.00 am ETA look at the top 10 most actives in...
whytestocks - April 16, 2024

NuCana Announces Completion of ADS Ratio Change

NEWS: $NCNA NuCana Announces Completion of ADS Ratio ChangeEDINBURGH, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- NuCana plc...
whytestocks - April 16, 2024

NCNA.....day 2 of volume and Price Action

On watch....no News Release No positon
Iseneschal - March 13, 2024